The Virologic and Immunologic Effects of Cyclosporine as an Adjunct to Antiretroviral Therapy in Patients Treated during Acute and Early HIV-1 Infection

被引:26
|
作者
Markowitz, Martin [1 ]
Vaida, Florin [4 ,5 ]
Hare, C. Bradley [4 ]
Boden, Daniel [1 ]
Mohri, Hiroshi [1 ]
Hecht, Frederick M. [4 ]
Kalayjian, Robert C. [7 ]
Conrad, Ann [7 ]
Mildvan, Donna [2 ]
Aberg, Judith [3 ]
Hogan, Christine [1 ]
Kilby, J. Michael [8 ]
Balfour, Henry H., Jr. [9 ]
Schafer, Kim [4 ,5 ]
Richman, Douglas [4 ,5 ,6 ]
Little, Susan [4 ,5 ]
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Div Infect Dis, New York, NY 10003 USA
[3] NYU, Sch Med, Dept Med, Div Infect Dis, New York, NY USA
[4] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
[5] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA
[6] Vet Adm San Diego Healthcare Syst, San Diego, CA USA
[7] Metrohlth Med Ctr, Dept Med, Cleveland, OH USA
[8] Univ Alabama, Dept Med, Birmingham, AL 35294 USA
[9] Univ Minnesota, Minneapolis, MN USA
来源
JOURNAL OF INFECTIOUS DISEASES | 2010年 / 201卷 / 09期
基金
美国国家卫生研究院;
关键词
CD4(+) T-LYMPHOCYTES; GASTROINTESTINAL-TRACT; DEPLETION;
D O I
10.1086/651664
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acute human immunodeficiency virus type 1 (HIV-1) infection is characterized by high levels of immune activation. Immunomodulation with cyclosporine combined with antiretroviral therapy (ART) in the setting of acute and early HIV-1 infection has been reported to result in enhanced immune reconstitution. Fifty-four individuals with acute and early infection were randomized to receive ART with 4 weeks of cyclosporine versus ART alone. In 48 subjects who completed the study, there were no significant differences between treatment arms in levels of proviral DNA or CD4(+) T cell counts. Adjunctive therapy with cyclosporine in this setting does not provide apparent virologic or immunologic benefit.
引用
收藏
页码:1298 / 1302
页数:5
相关论文
共 50 条
  • [21] HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1 - Infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccine
    Gilbert, PB
    Ackers, ML
    Berman, PW
    Francis, DP
    Popovic, V
    Hu, DJ
    Heyward, WL
    Sinangil, F
    Shepherd, BE
    Gurwith, M
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (06): : 974 - 983
  • [22] Beyond antiretroviral therapy: early interventions to control HIV-1 infection
    Gunst, Jesper D.
    Tolstrup, Martin
    Sogaard, Ole S.
    AIDS, 2017, 31 (12) : 1665 - 1667
  • [23] Primary HIV-1 infection: A review of clinical manifestations, immunologic and virologic changes
    Kaufmann, GR
    Duncombe, C
    Zaunders, J
    Cunningham, P
    Cooper, D
    AIDS PATIENT CARE AND STDS, 1998, 12 (10) : 759 - 767
  • [24] Epidemiology of discordant virologic and immunologic responses in HIV-1 infected patients
    Thiébaut, R
    Lewden, C
    Chêne, G
    MEDECINE ET MALADIES INFECTIEUSES, 2005, 35 : S31 - S32
  • [25] Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
    Gianella, Sara
    von Wyl, Viktor
    Fischer, Marek
    Niederoest, Barbara
    Battegay, Manuel
    Bernasconi, Enos
    Cavassini, Matthias
    Rauch, Andri
    Hirschel, Bernard
    Vernazza, Pietro
    Weber, Rainer
    Joos, Beda
    Guenthard, Huldrych F.
    ANTIVIRAL THERAPY, 2011, 16 (04) : 535 - 545
  • [26] Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy
    Voltersvik, P
    Dyrhol-Riise, AM
    Bostad, L
    Rosok, BI
    Olofsson, J
    Åsjö, B
    APMIS, 2000, 108 (7-8) : 539 - 550
  • [27] Prevention of HIV-1 Infection with Antiretroviral Therapy
    Rodger, Alison
    Phillips, Andrew
    Lundgren, Jens
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20): : 1934 - 1934
  • [28] ANTIRETROVIRAL COMBINATION THERAPY FOR HIV-1 INFECTION
    HERIDA, M
    PRESSE MEDICALE, 1995, 24 (23): : 1056 - 1058
  • [29] Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology
    de Souza, Mark S.
    Pinyakorn, Suteeraporn
    Akapirat, Siriwat
    Pattanachaiwit, Supanit
    Fletcher, James L. K.
    Chomchey, Nitiya
    Kroon, Eugene D.
    Ubolyam, Sasiwimol
    Michael, Nelson L.
    Robb, Merlin L.
    Phanuphak, Praphan
    Kim, Jerome H.
    Phanuphak, Nittaya
    Ananworanich, Jintanat
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (04) : 555 - 561
  • [30] Oxidative Imbalance in HIV-1 Infected Patients Treated with Antiretroviral Therapy
    Mandas, Antonella
    Iorio, Eugenio Luigi
    Congiu, Maria Gabriella
    Balestrieri, Cinzia
    Mereu, Antonello
    Cau, Daniela
    Dessi, Sandra
    Curreli, Nicoletta
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2009,